Insights On Enterprise Solutions

  1. Designing And Selecting Antibody-Oligonucleotide Conjugates 6/9/2026

    View antibody-oligonucleotide conjugate design, highlighting antibody formats, linker strategies, and screening methods to optimize delivery, stability, and gene-targeting therapeutic performance.

  2. AOC GMP Manufacture For A FIH Study 6/9/2026

    See an outline antibody-oligonucleotide conjugate manufacturing: process development, scale-up, GMP production, and analytical controls for efficient early-phase clinical material generation

  3. Self-Amplifying RNA: The Next Chapter In mRNA Therapeutics 6/5/2026

    Self-amplifying RNA builds on mRNA technology by enabling intracellular replication, delivering stronger and longer-lasting responses at lower doses while improving scalability, cost-efficiency, and global accessibility.

  4. Filling Gaps In Drug Discovery Pipelines: From Candidate To Clinic 6/5/2026

    See how existing partnerships with NIH allowed the chance to bring together government, academic, and industry resources through strategic initiatives that streamline processes and maximize benefits.

  5. Discovery, Characterization Of Epitope-Diverse MMR Protein Antibodies 6/5/2026

    Learn how these high-affinity, epitope-diverse mAbs provide a powerful toolkit to dissect the role of DNA mismatch repair (MMR) proteins in HD.

  6. Every Milliliter Matters: Maximizing Yield In Fill-Finish 6/4/2026

    A technical overview of minimizing product loss in aseptic fill‑finish processes, highlighting key loss points and practical strategies to improve yield, efficiency, and manufacturing consistency.

  7. India's Only GLP-Certified Viral Testing Facility 6/3/2026

    Get an overview of a GLP-certified viral testing facility that delivers comprehensive safety solutions, collaborative research support, and viral clearance data for biologics processes.

  8. Faster Clones, Simpler Process: What's Changing In CHO Expression? 6/3/2026

    This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

  9. What Can Our Global CRO/CDMO Services Do For You? 6/3/2026

    Explore the state-of-the-art multi-product, multi-client contract manufacturing facility that could serve as your one-stop shop for drug discovery, development, and manufacturing needs.

  10. Smarter By The Second Redefining Pharma Biopharma Manufacturing 6/2/2026

    Continuous monitoring is transforming manufacturing. With advanced analytics and sensor technologies, teams can detect issues early and optimize processes in real time for greater efficiency.